Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab)
Launched by UNIVERSITY OF CADIZ · Sep 20, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Virtendon-Rehab trial is studying the effectiveness of a virtual reality (VR) rehabilitation program for patients with chronic tendinopathy, which includes conditions like pain in the shoulder, elbow, knee, and Achilles tendon. Tendinopathy can lead to significant discomfort and limit daily activities, affecting about 30% of people with musculoskeletal injuries. This trial aims to see if using VR can make rehabilitation more engaging and effective by allowing patients to participate in fun, competitive exercises tailored to their individual needs.
To be eligible for the trial, participants should be aged 65 and older and have been diagnosed with one of the specific types of tendinopathy, with symptoms lasting more than six weeks. However, those who have had recent surgery, certain medical conditions that limit exercise, or recent treatments like corticosteroid injections will not be allowed to participate. If eligible, participants can expect to engage in a 12-week VR program, where their progress will be monitored and assessed for improvements in pain, function, and overall quality of life. This innovative approach hopes to enhance treatment for chronic tendinopathy while potentially reducing healthcare costs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of tendinopathy (shoulder rotator cuff tendinopathy, epicondylitis/epicondylitis, patellar tendinopathy, achilles tendinopathy).
- • Duration of symptoms: greater than 6 weeks.
- Exclusion Criteria:
- • People who have any pathology that prevents them from performing physical exercise.
- • Persons who have undergone surgery.
- • Persons who have an illness that may be a contraindication to the proposed procedure.
- • Persons who have received exercise therapy in the last 3 months.
- • Persons who have received corticosteroid injections in the last 3 months.
About University Of Cadiz
The University of Cádiz, an esteemed academic institution located in Spain, is dedicated to advancing medical research and clinical innovation through rigorous scientific inquiry. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that promotes the development of novel therapeutic strategies and enhances patient care. As a clinical trial sponsor, the University of Cádiz is committed to upholding the highest ethical standards and regulatory compliance, ensuring the safety and efficacy of its research initiatives while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cadiz, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported